Used in research for the treatment of autoimmune diseases such as psoriasis and lupus. Acts as an antagonist of the cannabinoid receptor 2 (CB2), helping to modulate immune response without psychoactive effects. Shows potential in reducing inflammation and controlling overactive immune activity in preclinical studies. Currently investigated for its efficacy and safety in inflammatory conditions, but not approved for clinical use.